Suchen
Sanofi SA
SNYZur Watchlist hinzufügen
43.160USD
+1.530+3.68%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
103.60BMarktkapitalisierung
12.00KGV TTM
mehr Informationen über Sanofi SA Unternehmen
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Sanofi SA Informationen
BörsenkürzelSNY
Name des UnternehmensSanofi SA
IPO-datumJul 01, 2002
CEOHudson (Paul)
Anzahl der mitarbeiter84587
WertpapierartDepository Receipt
GeschäftsjahresendeJul 01
Addresse46 Avenue de la Grande Armee
StadtPARIS
BörseNASDAQ OMX - NASDAQ BASIC
LandFrance
Postleitzahl75017
Telefon33153774000
Websitehttps://www.sanofi.com/
BörsenkürzelSNY
IPO-datumJul 01, 2002
CEOHudson (Paul)
Führungskräfte von Sanofi SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mr. Thomas Triomphe
Mr. Thomas Triomphe
Executive Vice President - Vaccines, Member of the Executive Committee
Executive Vice President - Vaccines, Member of the Executive Committee
--
--
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Mr. Wolfgang Laux
Mr. Wolfgang Laux
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Tran Yann
Mr. Tran Yann
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Roy Papatheodorou
Mr. Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Executive Vice President, General Counsel, Member of the Executive Committee
--
--
Mr. Brendan O' Callaghan
Mr. Brendan O' Callaghan
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
--
--
Ms. Carole Ferrand
Ms. Carole Ferrand
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mr. Thomas Triomphe
Mr. Thomas Triomphe
Executive Vice President - Vaccines, Member of the Executive Committee
Executive Vice President - Vaccines, Member of the Executive Committee
--
--
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Mr. Wolfgang Laux
Mr. Wolfgang Laux
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Tran Yann
Mr. Tran Yann
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Roy Papatheodorou
Mr. Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Executive Vice President, General Counsel, Member of the Executive Committee
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Sanofi SA?
Die fünf größten Anteilseigner von Sanofi SA sind: Ms. Julie Van Ongevalle
Wie viele Institutionen halten Anteile an Sanofi SA (SNY)?
Mit Stand vom 2026Q1 halten 1330 Institutionen Anteile an Sanofi SA, mit einem Gesamtmarktwert von etwa 225.52M, was 9.34% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -36323619.00 gestiegen.